Technical Analysis for ENZ - Enzo Biochem, Inc.

Grade Last Price % Change Price Change
F 1.25 3.31% 0.04
ENZ closed up 3.31 percent on Monday, March 18, 2024, on 79 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 19
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Gapped Up Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 3.31%
Below Lower BB Weakness 3.31%
Lower Bollinger Band Touch Weakness 3.31%
Oversold Stochastic Weakness 3.31%
Pocket Pivot Bullish Swing Setup -0.79%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 17 hours ago
Gap Up Partially Closed about 17 hours ago
2x Volume Pace about 17 hours ago
1.5x Volume Pace about 17 hours ago
Gapped Up (Partial) about 17 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enzo Biochem, Inc. Description

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Acid Diabetes Autoimmune Disease Antibodies Molecular Biology Gastrointestinal Cardiovascular Disease Drug Development Clinical Research Ophthalmic Neurological Disorders Genetic Engineering Lab Testing Gene Expression Obesity Metabolic Disease Peptides Urological Disorders Dyes Medical Laboratory Search Products Biochemistry Research Products Endocrine Disorders Medical Diagnosis Diagnostic And Research Products

Is ENZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.7262
52 Week Low 1.16
Average Volume 98,767
200-Day Moving Average 1.46
50-Day Moving Average 1.33
20-Day Moving Average 1.31
10-Day Moving Average 1.29
Average True Range 0.06
RSI (14) 40.83
ADX 24.67
+DI 8.59
-DI 21.52
Chandelier Exit (Long, 3 ATRs) 1.22
Chandelier Exit (Short, 3 ATRs) 1.39
Upper Bollinger Bands 1.40
Lower Bollinger Band 1.23
Percent B (%b) 0.14
BandWidth 13.32
MACD Line -0.02
MACD Signal Line -0.01
MACD Histogram -0.0118
Fundamentals Value
Market Cap 63.11 Million
Num Shares 50.5 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -2.45
Price-to-Sales 2.15
Price-to-Book 0.92
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.37
Resistance 3 (R3) 1.37 1.33 1.35
Resistance 2 (R2) 1.33 1.30 1.33 1.34
Resistance 1 (R1) 1.29 1.28 1.27 1.29 1.34
Pivot Point 1.25 1.25 1.24 1.25 1.25
Support 1 (S1) 1.21 1.22 1.19 1.21 1.16
Support 2 (S2) 1.17 1.20 1.17 1.16
Support 3 (S3) 1.13 1.17 1.15
Support 4 (S4) 1.13